Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease.
Saved in:
| Title: | Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's disease. |
|---|---|
| Authors: | Virachit S; Neuroscience Research Australia, Randwick, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia., Mathews KJ; Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia., Cottam V; Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia., Werry E; Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Galli E; Institute of Biotechnology, University of Helsinki, Helsinki, Finland., Rappou E; Institute of Biotechnology, University of Helsinki, Helsinki, Finland., Lindholm P; Institute of Biotechnology, University of Helsinki, Helsinki, Finland., Saarma M; Institute of Biotechnology, University of Helsinki, Helsinki, Finland., Halliday GM; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia.; Central Clinical School, University of Sydney, Sydney, Australia., Shannon Weickert C; Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, Australia.; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.; Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, NY., Double KL; Discipline of Pharmacology, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.; Brain and Mind Centre, University of Sydney, Sydney, Australia. |
| Source: | Brain pathology (Zurich, Switzerland) [Brain Pathol] 2019 Nov; Vol. 29 (6), pp. 813-825. Date of Electronic Publication: 2019 Jun 14. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: International Society of Neuropathology Country of Publication: Switzerland NLM ID: 9216781 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-3639 (Electronic) Linking ISSN: 10156305 NLM ISO Abbreviation: Brain Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
